Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL146128 | 0.96 | — | — | |
| Acetic Acid SCHEMBL31228715 | 0.96 | FFAR3 (0.54) | — | |
| Acetic Acid SCHEMBL27592793 | 0.93 | — | — | |
| Acetic Acid SCHEMBL4970317 | 0.93 | — | — | |
| Acetic Acid SCHEMBL2785265 | 0.93 | — | — | |
| Acetic Acid SCHEMBL10644131 | 0.93 | FFAR3 (0.50) | — | |
| Acetic Acid SCHEMBL27534278 | 0.87 | FFAR3 (0.44) | — | |
| Acetic Acid SCHEMBL21834420 | 0.87 | FFAR3 (0.44) | — | |
| Acetic Acid SCHEMBL29226934 | 0.85 | — | — | |
| Acetic Acid SCHEMBL4168552 | 0.85 | FFAR3 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080152652-A1 | Ligand for the c-kit receptor and methods of use thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2008-06-26 | — | — | US | disclosed |
| US-20050276784-A1 | Ligand for the c-kit receptor and methods of use thereof | SOLAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2005-12-15 | — | — | US | disclosed |
| US-20030125519-A1 | Stem cell factor; anticarcinogenic/antiproliferative/antitumor agents; antiallergens | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-07-03 | — | — | US | disclosed |
| US-20030103937-A1 | Ligand for the c-kit receptor and methods of use thereof | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2003-06-05 | — | — | US | disclosed |
| US-6403559-B1 | GERM CELLS, MAST CELLS AND MELANOCYTES; STEM CELL FACTOR | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | 2002-06-11 | — | — | US | disclosed |
| EP-0639979-B1 | LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF | SLOAN KETTERING INST BR FOR CA (US) | 2001-10-04 | — | — | EP | disclosed |
| EP-1127577-A2 | Ligand for the c-kit receptor and methods of use thereof | Sloan-Kettering Institute For Cancer Research (US) | 2001-08-29 | — | — | EP | disclosed |
| US-6159461-A | Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2000-12-12 | — | — | US | disclosed |
| US-6001803-A | Composition of c-kit ligand, GM-CSF, and TNF-α and method of use | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1999-12-14 | — | — | US | disclosed |
| US-5935565-A | ADMINISTERING TO THE MAMMAL A PHARMACEUTICAL COMPOSITION COMPRISING SOLUBLE C-KIT LIGAN POLYPEPTIDE, A HEMATOPOIETIC FACTOR OR FACTORS AND A CARRIER | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1999-08-10 | — | — | US | disclosed |
| US-5767074-A | COMPRISES A SOLUBLE C-KIT LIGAND PROTEIN AND ONE OR MORE HEMATOPOIETIC FACTORS SELECTED FROM INTERLEUKINS, GRANULOCYTE-MACROPHAGE-COLONY STIMULATING FACTOR, GRANULOCYTE-COLONYL STIMULATING FACTOR OR ERYTHROPOIETIN | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1998-06-16 | — | — | US | disclosed |
| EP-0639979-A4 | LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF. | SLOAN KETTERING INST CANCER (US) | 1996-10-23 | — | — | EP | disclosed |
| EP-0639979-A1 | LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF | Sloan-Kettering Institute For Cancer Research (US) | 1995-03-01 | — | — | EP | disclosed |
| EP-0546054-A4 | — | — | 1994-04-27 | — | — | EP | disclosed |
| WO-1993021936-A1 | LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1993-11-11 | — | — | WO | disclosed |
| EP-0546054-A1 | LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF | Sloan-Kettering Institute For Cancer Research (US) | 1993-06-16 | — | — | EP | disclosed |
| WO-1992003459-A1 | LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1992-03-05 | — | — | WO | disclosed |